- Recommendation ID
- NG231/05B
- Question
Frequency and duration of endoscopic follow-up: What is the optimal frequency and duration of endoscopic follow-up for patients who have received endoscopic treatment for stage 1 oesophageal adenocarcinoma?
- Any explanatory notes
(if applicable) For a short explanation of why the committee made this recommendation for research, see the rationale section on managing stage 1 oesophageal adenocarcinoma.
Full details of the evidence and the committee's discussion are in evidence review J: endoscopic and radiological follow-up after treatment.
Source guidance details
- Comes from guidance
- Barrett's oesophagus and stage 1 oesophageal adenocarcinoma: monitoring and management
- Number
- NG231
- Date issued
- February 2023
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 28/02/2023 |